Blended genome–exome sequencing reads key regions deeply and the rest of the genome shallowly, cutting costs and ancestry bias while preserving genetic insight.

The U.S. mortality rate reached a record low in 2025. But it lags behind peers due to persistent issues like chronic disease, gun violence and unequal healthcare access.

New research on hypertrophic cardiomyopathy shows how gene changes in heart muscle proteins drive sudden cardiac death, turning genetic results into clear guidance.

As more people go without insurance, hospital revenues decline, insurance premiums throughout the system increase and medical debt levels rise.

Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.

Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.

By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

A targeted antibody‑drug conjugate wipes out measurable residual disease in adult acute lymphoblastic leukemia, cutting relapse risk and extending long‑term survival.

The Bundibugyo strain of the Ebola virus has been devastating the Democratic Republic of the Congo, with no vaccine currently approved to protect against the strain.

In utero gene therapy uses prenatal genetic screening to identify fetuses with lethal mutations and delivers corrective genes before birth.